Eagle Pharmaceuticals Inc
NASDAQ:EGRX
Products, Litigation
Endo Comments On Non-Infringement Ruling In VASOSTRICT Patent Litigation
Published: 08/31/2021 18:17 GMT
Eagle Pharmaceuticals Inc (EGRX) - Endo Comments on Non-infringement Ruling in Vasostrict® Patent Litigation.
Endo International Plc - Because Court Found Non-infringement of Endo's Patents by Eagle's Proposed Product, It Did Not Rule on Patents' Validity.
Endo International Plc - to Appeal Court's Decision and Continue Defending Intellectual Property Rights to Vasostrict.
Endo International Plc - Because Court Found Non-infringement of Endo's Patents by Eagle's Proposed Product, It Did Not Rule on Patents' Validity.
Endo International Plc - to Appeal Court's Decision and Continue Defending Intellectual Property Rights to Vasostrict.